For example, patients with breast cancer harboring amplifications of the HER2 gene, found in 25% to 30% of breast cancers [149,150], have different prognoses than patients without such HER2 amplifications [151], regardless of what treatment is given. Here, ERBB2 is linked to breast cancer.